Your browser doesn't support javascript.
loading
Identification of distinct symptom profiles in patients with gynecologic cancers using a pre-specified symptom cluster.
Hammer, Marilyn J; Cooper, Bruce A; Chen, Lee-May; Wright, Alexi A; Pozzar, Rachel; Blank, Stephanie V; Cohen, Bevin; Dunn, Laura; Paul, Steven; Conley, Yvette P; Levine, Jon D; Miaskowski, Christine.
Afiliação
  • Hammer MJ; Dana-Farber Cancer Institute, Boston, MA, USA.
  • Cooper BA; School of Nursing, University of California, San Francisco, San Francisco, CA, USA.
  • Chen LM; School of Medicine, University of California, San Francisco, San Francisco, CA, USA.
  • Wright AA; Dana-Farber Cancer Institute, Boston, MA, USA.
  • Pozzar R; Dana-Farber Cancer Institute, Boston, MA, USA.
  • Blank SV; Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Cohen B; The Mount Sinai Hospital, New York, NY, USA.
  • Dunn L; School of Medicine, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
  • Paul S; School of Nursing, University of California, San Francisco, San Francisco, CA, USA.
  • Conley YP; School of Nursing, University of Pittsburgh, Pittsburgh, PA, USA.
  • Levine JD; School of Medicine, University of California, San Francisco, San Francisco, CA, USA.
  • Miaskowski C; School of Nursing, University of California, San Francisco, San Francisco, CA, USA. chris.miaskowski@ucsf.edu.
Support Care Cancer ; 31(8): 485, 2023 Jul 22.
Article em En | MEDLINE | ID: mdl-37480403
ABSTRACT

PURPOSE:

Pain, fatigue, sleep disturbance, and depression are four of the most common symptoms in patients with gynecologic cancer. The purposes were to identify subgroups of patients with distinct co-occurring pain, fatigue, sleep disturbance, and depression profiles (i.e., pre-specified symptom cluster) in a sample of patients with gynecologic cancer receiving chemotherapy and assess for differences in demographic and clinical characteristics, as well as the severity of other common symptoms and QOL outcomes among these subgroups.

METHODS:

Patients completed symptom questionnaires prior to their second or third cycle of chemotherapy. Latent profile analysis was used to identify subgroups of patients using the pre-specified symptom cluster. Parametric and nonparametric tests were used to evaluate for differences between the subgroups.

RESULTS:

In the sample of 233 patients, two distinct latent classes were identified (i.e., low (64.8%) and high (35.2%)) indicating lower and higher levels of symptom burden. Patients in high class were younger, had child care responsibilities, were unemployed, and had a lower annual income. In addition, these women had a higher body mass index, a higher comorbidity burden, and a lower functional status. Patients in the high class reported higher levels of anxiety, as well as lower levels of energy and cognitive function and poorer quality of life scores.

CONCLUSIONS:

This study identified a number of modifiable and non-modifiable risk factors associated with membership in the high class. Clinicians can use this information to refer patients to dieticians and physical therapists for tailored interventions.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Qualidade de Vida / Neoplasias dos Genitais Femininos Tipo de estudo: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Revista: Support Care Cancer Assunto da revista: NEOPLASIAS / SERVICOS DE SAUDE Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Qualidade de Vida / Neoplasias dos Genitais Femininos Tipo de estudo: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Revista: Support Care Cancer Assunto da revista: NEOPLASIAS / SERVICOS DE SAUDE Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos